Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This study wants to find out how safe and effective the use of Folfirinox combined with
Stereotactic Body Radiation Therapy )(SBRT) is for the treatment of pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville